Local stocks ended with modest gains after volatile session of trade. The barometer index, the S&P BSE Sensex, gained 269.43 points or 0.71% at 38,024.32, as per the provisional closing data. The Nifty 50 index rose 83.60 points or 0.74% at 11,426.85, as per the provisional closing data. Positive global stocks boosted sentiment.
The Sensex settled above the psychological 38,000 level after moving above and below that level in intraday trade. Domestic stocks nudged higher in early trade on positive Asian stocks. Key benchmark indices extended early gains and hit intraday high in morning trade. Stocks hovered in positive zone in mid-morning trade. Indices extended gains in afternoon trade. Strong buying demand in index pivotals pushed the key benchmark indices higher in mid-afternoon trade. Volatility zoomed in late trade as the key indices trimmed gains soon after hitting fresh intraday high in late trade.
The S&P BSE Mid-Cap index rose 0.55%. The S&P BSE Small-Cap index fell 0.34%.
The market breadth, indicating the overall health of the market, was negative. On the BSE, 1208 shares rose and 1476 shares fell. A total of 176 shares were unchanged.
Tech Mahindra rose 1.43%. Tech Mahindra's arm acquired 100% stake in Japan's K-Vision for $1.5 million. The target is engaged in providing network services for mobile communication carriers in Japan. The announcement was made after market hours yesterday, 14 March 2019.
Reliance Industries (RIL) fell 1.39%. Brookfield has filed the preliminary placement memorandum, in terms of which India Infrastructure Trust, an InvIT set up by Brookfield as sponsor and 90% investor, will invest Rs 13,000 crore to acquire the East West Pipeline (Pipeline). As a part of the transaction, the InvIT will acquire 100% equity interest in Pipeline Infrastructure Private Limited (PIPL) which currently owns and operates the Pipeline.
RIL's current investment in preference shares valued at Rs 4,000 crore will continue and will be converted into equity at the end of 20 years. Further at the end of 20 years, RIL has the right to acquire equity shares of PIPL held by the InvIT at an equity value of Rs 50 crore. The announcement was made after market hours yesterday, 14 March 2019.
Glenmark Pharmaceuticals rose 1.46%. Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for clindamycin and benzoyl peroxide gel, 1% / 5%, a generic version of BenzaClin Gel, 1% / 5%, of Valeant Bermuda. According to IQVIA sales data for the 12 month period ending January 2019, the BenzaClin Gel, 1% / 5% market achieved annual sales of approximately $99.4 million. The announcement was made during trading hours today, 15 March 2019.
Overseas, European equities were trading higher as all eyes remain on the trade talks. U.K. shares climbed after Prime Minister Theresa May won some time for a final push on her rejected Brexit deal. The U.K. Parliament voted to request an extension of the March 29 Brexit deadline to June 30 if lawmakers can agree to a withdrawal deal by March 20. Thursday's vote comes after Prime Minister Theresa May failed to secure support for her revised Brexit plan and lawmakers on Wednesday ruled out a no-deal exit.
Asian markets were trading higher Friday as China took a step to appease U.S. trade negotiators. The Bank of Japan kept its monetary policy steady on Friday in a widely expected move, where the short-term interest rate will remain at minus 0.1%.
US stocks closed mostly lower Thursday as investors digested headlines suggesting progress toward a US-China trade deal has stalled against the backdrop of weaker-than-expected Chinese economic data.
A meeting between President Donald Trump and Chinese President Xi Jinping will be delayed until at least April, as per reports, indicating that a bilateral trade deal will not be finalized this month.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
